Moving the boundaries of international collaboration on clinical trials and QoL
26 Mar 2013
In an article appearing in Expert Rev. Pharmacoecon. Outcomes Res. 13 ( 1 ), 43 – 45 ( 2013 )
Andrew Bottomley, Tony Kirby, John Bean, and Julie Walker review the 3rd EORTC Quality of Life, Symptom Research and Patient Reported Outcomes in Cancer Clinical Trials Conference held at The European Parliament, Brussels, Belgium, 17–20 October 2012
Related News
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
Beyond survival: new CSO and EORTC recommendations call for better reporting of quality of life in adjuvant cancer trials
30 Sep 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
